Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)

Clinical trial NCT06545136 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06545136
Sponsor: Spur Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gaucher Disease, Type 1

Start date: 2024-05-13
Primary completion: 2029-05-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.